dehydroepiandrosterone has been researched along with Overweight in 10 studies
Dehydroepiandrosterone: A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
dehydroepiandrosterone : An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands.
Overweight: A status with BODY WEIGHT that is above certain standards. In the scale of BODY MASS INDEX, overweight is defined as having a BMI of 25.0-29.9 kg/m2. Overweight may or may not be due to increases in body fat (ADIPOSE TISSUE), hence overweight does not equal over fat.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The objective of the study was to assess the therapeutic effects of rosiglitazone in overweight women with polycystic ovary syndrome (PCOS)." | 9.12 | Endocrine and metabolic effects of rosiglitazone in overweight women with PCOS: a randomized placebo-controlled study. ( Morin-Papunen, LC; Rautio, K; Ruokonen, A; Tapanainen, JS, 2006) |
| "This study tested the hypothesis that 3-acetyl-7-oxo-dehydroepiandrosterone alone (7-Keto) and in combination with calcium citrate, green tea extract, ascorbic acid, chromium nicotinate and cholecalciferol (HUM5007) will increase the resting metabolic rate (RMR) of overweight subjects maintained on a calorie-restricted diet." | 9.12 | HUM5007, a novel combination of thermogenic compounds, and 3-acetyl-7-oxo-dehydroepiandrosterone: each increases the resting metabolic rate of overweight adults. ( Frestedt, JL; Kuskowski, MA; Zenk, JL, 2007) |
| "The objective of the study was to assess the therapeutic effects of rosiglitazone in overweight women with polycystic ovary syndrome (PCOS)." | 5.12 | Endocrine and metabolic effects of rosiglitazone in overweight women with PCOS: a randomized placebo-controlled study. ( Morin-Papunen, LC; Rautio, K; Ruokonen, A; Tapanainen, JS, 2006) |
| "This study tested the hypothesis that 3-acetyl-7-oxo-dehydroepiandrosterone alone (7-Keto) and in combination with calcium citrate, green tea extract, ascorbic acid, chromium nicotinate and cholecalciferol (HUM5007) will increase the resting metabolic rate (RMR) of overweight subjects maintained on a calorie-restricted diet." | 5.12 | HUM5007, a novel combination of thermogenic compounds, and 3-acetyl-7-oxo-dehydroepiandrosterone: each increases the resting metabolic rate of overweight adults. ( Frestedt, JL; Kuskowski, MA; Zenk, JL, 2007) |
| "Obesity and mild unmedicated metabolic risk factors alter the circulating steroid profile and bias the estimation of reference limits for testosterone, dihydrotestosterone, cortisol and corticosterone." | 3.96 | Impact of age, body weight and metabolic risk factors on steroid reference intervals in men. ( Baccini, M; Di Dalmazi, G; Fanelli, F; Fazzini, A; Gambineri, A; Mezzullo, M; Pagotto, U; Pelusi, C; Repaci, A; Vicennati, V, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, SR | 1 |
| Bell, RJ | 1 |
| Robinson, PJ | 1 |
| Handelsman, DJ | 1 |
| Gilbert, T | 1 |
| Phung, J | 1 |
| Desai, R | 1 |
| Lockery, JE | 1 |
| Woods, RL | 1 |
| Wolfe, RS | 1 |
| Reid, CM | 1 |
| Nelson, MR | 1 |
| Murray, AM | 1 |
| McNeil, JJ | 1 |
| Cao, B | 1 |
| Gong, C | 1 |
| Wu, D | 1 |
| Liang, X | 1 |
| Li, W | 1 |
| Liu, M | 1 |
| Su, C | 1 |
| Qin, M | 1 |
| Meng, X | 1 |
| Wei, L | 1 |
| Mezzullo, M | 1 |
| Di Dalmazi, G | 1 |
| Fazzini, A | 1 |
| Baccini, M | 1 |
| Repaci, A | 1 |
| Gambineri, A | 1 |
| Vicennati, V | 1 |
| Pelusi, C | 1 |
| Pagotto, U | 1 |
| Fanelli, F | 1 |
| Wise-Oringer, BK | 1 |
| Burghard, AC | 1 |
| Park, H | 2 |
| Auchus, RJ | 1 |
| Oberfield, SE | 1 |
| Uhlemann, AC | 1 |
| Kwon, JH | 1 |
| Lee, HA | 1 |
| Kim, YJ | 1 |
| Lee, H | 1 |
| Park, EA | 1 |
| Cho, SJ | 1 |
| Gwak, HS | 1 |
| Ha, E | 1 |
| Kim, HS | 1 |
| Giannini, A | 1 |
| Genazzani, AD | 1 |
| Napolitano, A | 1 |
| Caretto, M | 1 |
| Stomati, M | 1 |
| Simoncini, T | 1 |
| Genazzani, AR | 1 |
| Diaz, A | 1 |
| Bhandari, S | 1 |
| Sison, C | 1 |
| Vogiatzi, M | 1 |
| Miller, GD | 1 |
| Nicklas, BJ | 1 |
| Davis, CC | 1 |
| Legault, C | 1 |
| Messier, SP | 1 |
| Rautio, K | 1 |
| Tapanainen, JS | 1 |
| Ruokonen, A | 1 |
| Morin-Papunen, LC | 1 |
| Zenk, JL | 1 |
| Frestedt, JL | 1 |
| Kuskowski, MA | 1 |
4 trials available for dehydroepiandrosterone and Overweight
| Article | Year |
|---|---|
Oral dehydroepiandrosterone restores ß-endorphin response to OGTT in early and late postmenopause.
Topics: Administration, Oral; Aged; Androgens; beta-Endorphin; Dehydroepiandrosterone; Female; Glucose; Gluc | 2019 |
Basal growth hormone concentration increased following a weight loss focused dietary intervention in older overweight and obese women.
Topics: Aged; Aging; Dehydroepiandrosterone; Female; Human Growth Hormone; Humans; Hydrocortisone; Male; Nut | 2012 |
Endocrine and metabolic effects of rosiglitazone in overweight women with PCOS: a randomized placebo-controlled study.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Area Under Curve; Dehydroepiandrosterone; Double-Bl | 2006 |
HUM5007, a novel combination of thermogenic compounds, and 3-acetyl-7-oxo-dehydroepiandrosterone: each increases the resting metabolic rate of overweight adults.
Topics: Adult; Ascorbic Acid; Basal Metabolism; Caloric Restriction; Camellia sinensis; Cholecalciferol; Deh | 2007 |
6 other studies available for dehydroepiandrosterone and Overweight
| Article | Year |
|---|---|
Testosterone and Estrone Increase From the Age of 70 Years: Findings From the Sex Hormones in Older Women Study.
Topics: Aged; Aged, 80 and over; Aging; Biomarkers; Community-Based Participatory Research; Cross-Sectional | 2019 |
A cross-sectional survey of adrenal steroid hormones among overweight/obese boys according to puberty stage.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Cortex Hormones; Age Factors; Androstenedione; Chi | 2019 |
Impact of age, body weight and metabolic risk factors on steroid reference intervals in men.
Topics: 17-alpha-Hydroxyprogesterone; Age Factors; Androstenedione; Body Mass Index; Body Weight; Chromatogr | 2020 |
Salivary microbiome differences in prepubertal children with and without adrenal androgen excess.
Topics: Androgens; Child; Cross-Sectional Studies; Dehydroepiandrosterone; Humans; Microbiota; Obesity; Over | 2022 |
Effects of Adrenal Androgen Levels on Bone Age Advancement in Prepubertal Children: Using the Ewha Birth and Growth Cohort Study.
Topics: Adrenal Cortex Hormones; Age Determination by Skeleton; Age Factors; Androstenedione; Anthropometry; | 2017 |
Characteristics of children with premature pubarche in the new york metropolitan area.
Topics: Age Determination by Skeleton; Child; Child, Preschool; Dehydroepiandrosterone; Dehydroepiandrostero | 2008 |